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Conventional adenovirus vectors harboring E1 or E3 deletions followed by the insertion of an exogenous
gene show considerably reduced virion stability. Here, we report strategies to generate complete re-
plication-competent Ad11p(RCAd11p) vectors that overcome the above disadvantage. A GFP cassette was
successfully introduced either upstream of E1A or in the E3A region. The resulting vectors showed high
expression levels of the hexon and E1genes and also strongly induced the cytopathic effect in targeted
cells. When harboring oversized genomes, the RCAd11pE1 and RCAd11pE3 vectors showed signiﬁcantly
improved heat stability in comparison to Ad11pwt;of the three, RCAd11pE3 was the most tolerant to heat
treatment. Electron microscopy showed that RCAd11pE3, RCAd11pE1, Ad11pwt, and Ad11pE1 Delmani-
fested dominant, moderate, minimum, or no full virus particles after heat treatment at 47 °C for 5 h. Our
results demonstrated that both genome size and the insertion site in the viral genome affect virion
stability.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Oncolytic or replication-competent adenovirus (Ad) vectors are
considered promising virotherapy vehicles of high utility because
they can be easily constructed, are produced at high titers, and can
efﬁciently transduce various types of cells. Most commonly, the Ad
vectors that are used for clinical purposes are based on adenovirus
serotype 5 (Ad5), which belongs to subgroup C. In recent years,
however, it has become apparent that Ad5 vectors have some
drawbacks, such as the high seroprevalence of anti-Ad5 antibodies
in adult humans and the low transduction efﬁciency of Ad5 vec-
tors in cells lacking the primary receptor for Ad5, the coxsack-
ievirus and adenovirus receptor (CAR), which is the case for nu-
merous types of metastatic solid tumors and leukemia cells. This
critical roadblock could be overcome by using an alternative ser-
otype of the virus to bypass the presence of pre-existing anti-
bodies that have been elicited by previous natural Ad infections.Inc. This is an open access article u
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. Hultenby),The replication competent Ad11 vector could be used to overcome
the disadvantages associated with Ad5 vectors, as species B Ad11
also uses DSG-2 and CD46 as receptors (Wang et al., 2011), which
are ubiquitously expressed on metastatic tumor cells, and Ad11
shows a low seroprevalence in humans. Indeed, only approxi-
mately 10–31% of the population is seropositive for Ad11, whereas
up to 90% of the population is seropositive for Ad5. Notably, there
is no serum cross reactivity between Ad11 and Ad5 (Holterman
et al., 2004; Stone et al., 2005).
A number of species B Ads, such as Ad3, Ad7, Ad11 and Ad35,
have been developed as gene therapy or vaccine vectors. Such
vectors have primarily been designed according to conventional
methodology: they incorporate an E1 deletion followed by sub-
stitution with an expression cassette. Such vectors display char-
acteristics common to Ad, showing low production and heat la-
bility, and they satisfy the requirements needed to produce virus
in packaging cell lines. Replication-competent Ad11 vectors have
also been reported by Wong et al. (2012). To create these vectors,
the promoter-enhancer and promoter sequence from 195 nt to 358
nt of Ad5 were replaced with a sequence fragment from 249 nt to
392 nt of Ad11p, resulting in Ad11p-Ad5-EP vectors that could
replicate in a greater variety of cancer cell lines than the parent
viruses.
Ad E1A, a multifunctional protein expressed early after infec-
tion, interferes with numerous important regulatory processes by
interacting with host cell proteins or directly transcriptionally
activating target genes. Although E1A was initially identiﬁed as annder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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rodent cells, this protein has also been shown to possess remarkable
tumor suppressive effects on various types of human cancer cells
(Frisch, 1991; Frisch and Mymryk, 2002). For instance, E1A down-
regulated HER2/neu expression in addition to participating in other
antitumor mechanisms unrelated to Her-2 (Chang et al., 1997). E1A
also negatively regulates cellular proteins that are important for
gene transcription, such as p300/CBP, TATA-binding protein, TBP-
associated factors, NF-kB, ATF-4 and c-Jun (Brockmann et al., 1995;
Chen and Hung, 1997; Liang and Hai, 1997). The E1A protein has
also been shown to induce sensitization to anticancer drug-induced
apoptosis, as well as to reduce tumor metastasis and promote
apoptosis under conditions of serum deprivation caused by the
application of tumor necrosis factor a (TNF-a), irradiation or antic-
ancer agents such as Taxol, etoposide, and Adriamycin. For these
reasons, E1A-based viral gene therapies have been extensively
exploited in both pre-clinical and clinical settings. Thus, there is a
need to keep the E1 gene intact, and recent studies have focused on
creating Ad vectors that include a therapeutic gene insertion in the
E3 region as opposed to in the E1 region. The E3 region of the Ad
genome has been previously shown as unnecessary for virus re-
plication and can therefore be deleted to introduce a large expres-
sion cassette for therapeutic purposes. However, this concept has
been challenged by recent reports indicating that the re-introduc-
tion of full-length E3 back into the virus genome increases its
therapeutic efﬁcacy (Danielsson et al., 2008). Thus, the deletion of
E3 may affect viral function.
From the perspective of studying the oncolytic capacities of Ad
vectors, the receptor-restricted expression of Ad is unfortunate.
Wild-type Ad can induce oncolysis in some cells, but it is not
possible to directly quantify the receptor-restricted transduction of
the virus. In contrast, replication-defective Ad vectors with quan-
tiﬁable marker genes in the E1 region (i.e., GFP or luciferase) can
be monitored for viral entry and gene expression in the nucleus,
but their cytolytic properties are suboptimal due to the lack of
expression of the E1A transactivating gene. In addition, the re-
plication capacities of such defective vectors are considerably
lower than that of wild-type virus. Thus, these defective vectors
cannot be reliably used as a control to study Ad cytolysis.
Many studies have recently focused on the development of
recombinant Ad vectors harboring modiﬁcations of the E1 pro-
moter (Gaynor et al., 1982; Grable and Hearing, 1990; Osborne
et al., 1982); however, no report has yet addressed the possibility
of inserting a reporter gene into the full-length E1 region without
disrupting either the function of the packaging signal or the
transactivation activity of the product of the E1A open reading
frame (ORF). For the E3 Ad vector, commercial deletion of the
E319K ORF reduced cytotoxicity in MHC class I presenting cells, a
ﬁnding that might not be suitable for oncolytic purposes. To
overcome these limitations, in the current work, we present novel
strategies for the insertion of expression cassettes without any
deletion of the E1 region or with limited deletion of the E3 region
in the Ad 11p genome; we designated these constructs replication-
competent adenovirus E1GFP (RCAd11pE1GFP) and replication-
competent adenovirus E3GFP (RCAd11pE3GFP), respectively. These
replicating Ad11p viruses possess wild-type viral replication ca-
pacity, high GFP expression, and enhanced virion heat stability.2. Results
2.1. Characteristics of RCAd11pE1GFP, RCAd11pE3GFP, and Ad11-
pe1DelGFP vectors
The strategies used to construct recombinant replication-com-
petent adenovirus 11p e1 GFP (RCAd11pE1GFP or E1GFP), andreplication-competent adenovirus 11p e3 GFP (RCAd11pE3GFP or
E3GFP) vectors are illustrated in Fig. 1A–D. The construction of re-
plication-incompetent adenovirus 11p E1Del GFP (Ad11pE1DelGFP
or E1DelGFP) vector is described in materials and methods. The
genome sizes were 36,523 bp for RCAd11pE1GFP, an increase of
4.97% over the unmodiﬁed Ad11p wild type genome; 35,403 bp for
RCAd11pE3GFP, an increase of 1.75% over the Ad11p genome; and
33,624 bp for Ad11pE1Del GFP, a decrease of 3.36%, compared to the
Ad11p genome. Additional biological characteristics of the Ad11p
vectors, such as insertion sites, GC contents, deletions, modiﬁca-
tions, and packaging cell lines, are summarized in Table 1.
2.2. The E1 insertion did not disrupt transcription of the E1A and E1B
genes
A549 cells infected with Ad11pwt, RCAd11pe1 and RCAd11pE3
viruses showed successful transcription of the E1A gene. Using RT-
PCR, two E1A splice forms were identiﬁed at 7 h p.i. at the in-
dicated 268R and 231R fragments. By increasing the incubation
time to 24 or 48 h, an additional E1A fragment of 58R could be
visualized on an agarose gel. Similarly, the ability of the
RCAd11pGFP and Ad11pwt viruses to produce E1B 55k and E1B
pIX mRNA in virus-infected cells was also detected by RT-PCR
using two pairs of speciﬁc primers. As shown in Fig. 2A, the 55 K
and pIX ORFs were both detectable at 24 h p.i., and their transcript
levels increased by 48 h p.i. A slight reduction in the E1B ORF
transcript levels for RCAd11pe1GFP was observed in the RT-PCR
assay. However, all detected mRNAs induced by Ad11pwt or
RCAd11pGFPs were highly similar and comparable (Fig. 2A).
2.3. qPCR to detect E1A and hexon gene expression in A549 cells
To ensure that the insertion upstream of the E1A gene in the
RCAd11pE1 vector does not negatively affect virus replication, we
analyzed E1A mRNA levels by quantitative reverse-transcription
PCR using Ad11pE1A-speciﬁc primers. Ad11pwt and RCAd11pE3
vectors possess an identical E1A sequence, and the qPCR results
showed similar levels of E1A gene expression at time points of 2, 8,
24 and 48 h. In contrast, the RCAd11pE1 vector, which carries an
additional GFP sequence upstream of the E1A region, showed re-
latively higher E1A expression at 2 h p.i. Interestingly, the cells
infected with the RCAd11pE1 vector also showed higher levels of
E1A gene expression than the cells infected with the Ad11pwt or
RCAd11pE3 vectors at 48 h and 72 h p.i. Not unexpectedly, E1A
gene expression ranged from log 4 to log 5, and hexon gene ex-
pression ranged from log 5 to log 7 at 24 h and 72 h p.i. In general,
the Ad11pwt, E1GFP, and E3GFP viruses led to comparable levels of
E1 and hexon gene expression (Fig. 2B and C).
2.4. Kinetics of GFP expression following infection with RCAd11pE1
or RCAd11pE3 viruses in A549 cells
Electron microscopy images of virions from the RCAd11pE1
vector showed intact capsids with classical species B Ad mor-
phology. Virions with full genomes and short ﬁbers as well as
viruses lacking DNA were observed, as shown in Fig. 3A. The virus
products from each vector were compared with that of wild-type
Ad11p in A549 cells, and the multiplicities of infection for each
viral preparation were determined by TCID50 values for both A549
and HEK293 cells. A total of 5.41013 vp or 15 mg virion/batch
was obtained from each preparation. The ratio of infectious par-
ticles to physical particles was further studied using a TCID50 as-
say; one infectious particle among 72 viruses or less was detected
for the two Ad11pGFP vectors as well as the Ad11pwt virus. This
result was in agreement with our previous data (Mei et al., 1998).
Thus, the inclusion of a GFP insert at the front of the E1 region or
Fig. 1. Strategy for insertions into the E1A and E3 regions of the Ad11p genome. (A) The insertion site for a GFP expression cassette upstream of the E1A or E3A region of the
Ad11p genome. The thick line in the middle represents the adenovirus genome with its nucleotides marked off from the 5′ end. The structures of the mRNA and DNA
corresponding to the non-coding strand in the 5′ terminus of the E1A gene are shown above the line. þ1 corresponds to a nucleotide position 568 bp from the 5′ end of the
Ad11p genome. One translation initiation codon and three splicing ORFs are marked above the genome. The RCAd11pe1 and RCAd11pe3 constructs encode GFP reporter
genes in the E1 and E3 regions, respectively. (B) The 5′ DNA sequence of Ad11p. The nucleotides spanning from þ1–137 bp are known as the inverted terminal repeat (ITR).
The downstream strand of the ITR, ranging from nucleotides 249 to 392, is a packaging region that consists of I to VII repeats. The E1A promoter sequence (479–568 bp) and
CAAT and TATA homologous regions are depicted by open rectangles. (C) Strategy for the development of replication-competent adenovirus 11p containing the green
ﬂuorescent protein (GFP) gene in early region 1 (RCAd11pe1GFP). The E1 shuttle vector contains a kanamycin selective gene. The two arms of the E1GFP shuttle vector were
released by Sca I digestion and then cloned into the Ad11p genome through homologous recombination in BJ5183 cells. (D). Strategy for the development of replication-
competent adenovirus 11p containing the green ﬂuorescent protein (GFP) gene in early region 3 (RCAd11pe3GFP). The E3 shuttle vector contained a kanamycin resistance
gene. The two arms of the E3GFP shuttle vector were released by Nae I digestion and then cloned into the Ad11p genome through homologous recombination in BJ5183 cells.
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or the multiplicity of infection (TCID50).
We further quantiﬁed GFP levels in A549 cells using a ﬂow cyto-
metry assay (FACS). GFP expression following infection with the
RCAd11pE1 vector was visible starting at 2 h p.i., whereas the
RCAd11pE3 vector initiated GFP expression at 4–5 h p.i. A higher levelof expression was obtained with the RCAd11pE1 vector than the
RCAd11pE3 vector during the initial infection. However, there were no
detectable differences between the two vectors with regard to GFP
expression in A549 cells at 36 h p.i. or later (Fig. 3B). This ﬁnding in-
dicates that the transcription of the inserts in the Ad11p genome was
time-dependent and followed the natural transcription patterns of Ad.
Fig. 1. (continued)
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in A549 and HEK293 cells
To verify viral infectivity, puriﬁed viruses corresponding to
0.1 pg/cell were used to infect A549 and HEK293 cells. GFPexpression and the induced CPE were detected by ﬂuorescence
microscopy and light microscopy, respectively. GFP expression was
visualized at 10 and 12 h p.i. (Fig. 3C), and CPEs appeared at 24 h p.i.
(Fig. 3D). Both GFP expression and CPE were clearly detectable at
36 h p.i. with RCAd11pE1GFP and RCAd11pE3GFP (Fig. 3E). In
Table 1
Comparison of genome and biological properties among Ad11p vectors and Ad11pwt.
Topics Ad11pwt RCAd11pE1GFP RCAd11pE3GFP Ad11pE1delGFP
Sizes of the genome 34,794 bp 36,523 bp 35,403 bp 33,624 bp
G-C contents (GC/AT) 48.88% (17006/17788) 48.79% (17819/18705) 49.11% (17385/18018) 49.12% (16517/17107 )
Deletion No No E3 20.3 and 20.6K E1 region from 507 to 3405 bp
Insertion No CMV-GFP-SV40 1729 bp CMV-GFP-SV40 1729 bp CMV-GFP-SV40 1729 bp
Insertion site No 451 bp from 5′–3′ 28,355 bp from 5′–3′ 451 bp from 5′–3′
Orientation of insertion No Reverse Forward Reverse
Additional modiﬁcation No No Cre-Lox site at E3A region No
IP/VP aTCID50 Z1/72 Z1/72 Z1/72 NDb
a IP: infectious particle. VP: total virus particles. TCID50: Tissue culture infectious dose.
b ND: Not determinant.
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RCAd11pe3GFP viruses were comparable to that observed in the
cells that were infected with the Ad11pwt virus (Fig. 3C–E).
2.6. Measurements of virus stability
We analyzed the stability of RCAd11pE1, RCAd11pE3, Ad11-
pE1DelGFP, and Ad11pwt constructs containing genomes ranging
from 33.6 to 36.5 kbp in size (Table 1). To determine whether
Ad11p vectors with different genome sizes exhibited similar sta-
bility, each construct was submitted to heat stress, after which the
infectivity of each was measured in A549 cells based on GFP ex-
pression or ﬂuorescence antibody staining. The Ad11pwt construct
containing a 34.8-kbp genome showed an approximately 50% re-
duction in infectivity after being incubated at 47 °C for one hour
(Fig. 4A). Under the same conditions, the RCAd11pE1GFP vector
containing a 36.5-kbp genome exhibited a 30% reduction in viral
infectivity and displayed 20% more infectious than treated
Ad11pwt virus. Interestingly, the RCAd11pE3 vector possessing a
35.4-kbp genome showed almost full infectivity over the same
time course, and when we extended the heat treatment to 2 h,
there was less than a 10% reduction in infectivity. The RCAd11pE1
and RCAd11pE3 vectors possessed 65% and 92% infectivity after
heat stress that enhanced heat stability: approximately 25–52%
more virus survived than the wild-type counterpart (40%)
(Fig. 4A). In contrast, the stability of the Ad11pE1Del vector with
the smallest genome size, 33.6 kb, was dramatically inﬂuenced by
the heat treatment: only 10% of its original infectivity remained
after exposure to 47 °C for 1 h; and loss infectivity for 2 h. Thus,
the Ad11pE1DelGFP vector becomes increasingly heat sensitive as
its genome size decreases. The heat lability of the defective Ad11p
vector is consistent with observations made from other defective
Ad5 vectors (Bett et al., 1994; Hoffmann et al., 2007; Smith et al.,
2009) (Fig. 4A).
2.7. Viral infectivity at stringently elevated temperatures
To determine whether the Ad11p vectors could tolerate further
heat stress, a virus stability assay with an increased incubation time
and temperature was employed. After heating at 47 °C for 5 h,
Ad11pwt exhibited only 9.3% of the viral genome expression pro-
duced from corresponding untreated virus. In contrast, E1GFP
exhibited 34.4% of the GFP expression produced from corre-
sponding untreated virus, and E3GFP showed a 66.1% increase in
GFP expression over untreated virus (Fig. 4B). We did not test the
E1DelGFP vector because it lost GFP expression after 2 h of treat-
ment. After a stringent heat treatment at 50 °C for 30 min, E1GFP
and E3GFP exhibited 66% and 80.5% of the GFP expression pro-
duced by the corresponding untreated viruses, whereas Ad11pwt
exhibited 39% of the viral genome expression produced byuntreated virus (Fig. 4C). These results demonstrate that E1GFP
and E3GFP vectors have improved thermal stability.
2.8. Electron microscopy revealed the distinct morphologies of the
Ad11p vectors
The ultra-structures of the Ad11p vector and Ad11pwt viruses
before and after treatment at 47 °C for 5 h were investigated in
parallel using EM. Before the heat treatments, dominant full virus
particles (white particles) and limited empty virus particles (o1–
5%, dark particles) were observed in all four samples. The back-
grounds in these images were relatively clean. Further observa-
tions of heat-treated viruses showed populations of both full viral
particles and empty viral particles, as well as dissociated virus
particles, in all of the samples. However, the different samples had
varying ratios of these three morphologies. After exposure to heat
stress, the Ad11pwt sample had a majority (60–70%) of dissociated
and empty virus particles. In contrast, under the same heat
treatment protocol, the E3GFP and E1GFP samples contained many
full virus particles (70% of the particles counted for E3GFP were
full, while 50% of those counted for E1GFP were full) and far fewer
dissociated and empty virus particles than the Ad11pwt sample
(Fig. 5B and C). The Ad11E1Del sample showed a majority of dis-
sociated and empty virus particles and hardly any full virus par-
ticles (Fig. 5D).
Capsid morphology and protein content did not differ between
the various Ad11p vectors. The capsids of E1DelGFP had small
genomes that quickly fell apart when heated. EM revealed that
heating resulted in the release of the vertex proteins (i.e., the ﬁber
and the penton and most likely the peripentonal hexon), followed
by the exit of viral DNA from the virus particles, resulting in many
empty virus particles. This in turn led to the complete disin-
tegration of the capsid structure. In contrast, the RCAd11pE1
vector did not exhibit much release of vertex protein compared to
the wild type virus, and the RCAd11pe3 vector showed very low
release of vertex protein. Thus, investigating the ultrastructures of
these adenoviruses with and without heat treatment showed that
the E3GFP vector was the most stable followed by the E1GFP
vector, the E1DelGFP vector and, ﬁnally, wild type Ad11p. There-
fore, we RCAd11pe1 and RCAd11pE3 are more stable than wild
type virus.
2.9. Virus titers substantially differed after heat treatment
After incubation at 47 °C for 5 h, the infectivity of Ad11wt,
E1GFP and E3GFP was measured according to the TCID50. The
E3GFP and E1GFP vectors were more infectious than Ad11pwt
virus. The infectious particle to total virus particle (IP/VP) ratios
were 1:1.126103 or 1:1.129104 for E3GFP and 1:1.126105–
1:3.16105 for E1GFP. Ad11pwt displayed a lower virus titer at
Fig. 2. (A) Comparison of E1A and E1B transcripts. RT-PCR products from DNase-
treated RNA isolated from wild-type Ad11p (Ad11pwt)-, RCAd11pe1GFP-, or
RCAd11pe3GFP-infected A549 cells using E1A-, E1B 55K-, and E1B pIX-speciﬁc
primer pairs. The E1A transcriptional units of RCAd11pe1 were detected by RT-PCR
with three separate primer pairs to monitor each of the three E1A ORFs. Total RNA
was extracted from infected cells at the indicated time points. RNA from mock-
infected cells was used as a negative control for RT-PCR, and reactions with no
cellular RNA were used as controls for the PCR reaction. (B) and (C) Quantitation of
adenovirus progeny production in A549 cell lines by qPCR. Cell monolayers were
infected with 0.1 pg Ad11pwt, RCAd11pE1GFP, and RCAd11pE3GFP vectors (IP/VP at
least Z1/72). Ad11pwt virus at 2 h p.i. was used as a control. After the cell
monolayers were extensively washed, the quantity of virus recovered from the
medium was assayed at 2, 8, 24, 48 and 72 h p.i. via qPCR. The increase in ade-
novirus copy number is shown. E1A and hexon gene expression in A549 cells was
used to quantify progeny DNA at ﬁve different time points p.i. To accomplish this,
DNA was prepared from cells and viruses and analyzed by qPCR. Beta-actin was
included in the assay as a control, and all values are normalized to beta-actin. The
error bars represent the standard deviations of the means from three independent
experiments run in duplicate. Fig. 2B shows the qPCR results for the E1A gene.
Fig. 2C shows the qPCR results for the hexon gene. Note: E1GFP represents
RCAD11pE1GFP, and E3GFP represents RCAd11pE3GFP.
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showed that the E3GFP vector manifested the highest infectivity
(the ratio of IP/VP was 1:3.2102–1:7.7102), the E1GFP vector
manifested moderate infectivity (IP/VP: 1:1.1103–1:3.2103),
and Ad11pwt manifested minimal infectivity (1:1.1106–
1:3.2106) (Fig. 6). After another incubation at 55 °C for 30 min,
all three viruses lost infectivity. The virus titers (TCID50) of Ad11p
wt, E1GFP, and E3GFP were similar before the heat treatments, as
shown in Fig. 6.
RCAd11p vectors with oversized genomes showed signiﬁcantly
improved heat stability in comparison with wild-type virus. We
also explored how the use of different insertion sites in the viral
genome affects viral heat stability. The RCAd11pE3GFP vector
containing a 35,4-kbp genome, representing an increase of 1.7% of
its initial genome size (Table 1), was the most resistant to heat
stress. In contrast, the RCAd11pE1GFP vector containing a 36.5-
kbp genome, representing an increase of 4.9% of its initial genome
size, had better stability than Ad11pwt but less stability than
RCAd11pE3. Thus, we demonstrated that the locations of insertion
and substitution sites in the viral genome play important roles in
maintaining a stable structure for the virus. In addition, ordinary
endpoint titrations were conducted for all four viruses before and
after heat stress in A549 cells. Thus, the endpoint titrations for the
RCAd11p vectors and Ad11pwt supported the data from the Tro-
phos Plate Runner HD (Trophos, Marseille, France).3. Discussion
In the current study, we describe the construction and char-
acterization of an Ad11p vector system consisting of replication-
competent Ad11pGFP vectors harboring insertions of up to 1.7 kbp
in the E1 region or substitutions at the E3A region in combination
with a wild-type E1 region. We also constructed a defective Ad11p
vector. We demonstrated that the RCAd11pE1 and RCAd11pe3
vectors efﬁciently expressed the E1, hexon, and GFP genes while
showing improved virion heat stability. From the virological point
of view, our present ﬁndings improve conventional Ad5 vectors
that harbor deletions followed by insertions, which typically show
low yield and produce unstable viruses.
In this study, we focused on the region of the Ad11p genome
spanning from nt 1 to nt 580 of the 5′ end (Fig. 1A and B) (Chro-
boczek et al., 1992; Mei et al., 2003). Each end of the Ad genome
contains an inverted terminal repeat (ITR) that is 137 nts long; the
ITRs of the Ad11p genome show 65% identity to those of the Ad5
genome. The encapsidation region is located between nts 249 and
392 in the Ad11p genome and shows 67.4% identity to the same
region in the Ad5 genome. A repeated element that is crucial for
packaging has been identiﬁed in the Ad5 genome. The Ad genome
contains two distinct elements located at its 5′ end. One element,
which is repeated at nt positions 200–300, speciﬁcally regulates
E1A transcription in vivo; the second element, located between nt
positions 250 and 280, regulates the activity of all early viral
transcriptional units (Hearing and Shenk, 1986). The packaging
signal at the 5′ end of the Ad5 genome is located between nts 194
and 358, whereas this same domain in Ad16 is situated between
nts 290 and 390 (Hammarskjold and Winberg, 1980; Hearing and
Shenk, 1983). The E1A promoter is unique among Ad promoters. It
is the only promoter that must function efﬁciently during the
earliest stages of infection, before E1A proteins are expressed. The
E1A promoter region also includes a typical TATA box. As in other
promoters, the TATA box determines the transcription start site.
Deletion of the E1A TATA sequence decreases the level of E1A
mRNA by a factor of 5–10 and shifts the mRNA 5′ ends (Hearing
Fig. 3. (A) GFP expression in RCAd11pGFP viruses at 2–10 h p.i. (B) Kinetics of GFP expression mediated by RCAd11pe1 and RCAd11pe3 vectors in vitro. Subconﬂuent A549
cells were infected with the two viruses at 1 pg/cell. At the indicated time points after infection, GFP expression was detected by immunoﬂuorescence microscopy. In a
parallel experiment, the cells were harvested and examined by FACS analysis at time points ranging from 2 h to 36 h p.i. (C), (D), and (E) Viral cytopathic effects were
examined by light microscopy and ﬂuorescence microscopy at 12, 24, and 36 h p.i. NC: mock-infected cells; Ad11wt: wild-type Ad11p-infected cells; E1: RCAd11pe1GFP-
infected cells; E3: RCAd11e3GFP-infected cells. All cells were photographed at 200 magniﬁcation.
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the TATA sequence is necessary for efﬁcient transcription. The role
of the E1A gene product is to activate transcription from other
early viral regions. Thus, a functional E1A gene appears to be re-
quired during lytic infection for the accumulation of stable, early
viral mRNAs (Berk et al., 1979; Jones and Shenk, 1979). We have
demonstrated that the packaging domain and E1A promoter re-
gion can be separated into two parts via the introduction of an
expression cassette. The replication of Ad11p was unaffected by
this insertion (Schmid and Hearing, 1998). The sequence down-
stream of the Ad11p packaging signal was bounded at the 5′ end
by the ATG start code of the E1A gene.
E1A expression is one of the earliest steps of virus replication
and leads to the production of viral progeny. Variations in E1A
expression levels have been shown to account for the differential
effectiveness of therapeutic viruses. In the current study, a GFP
cassette was inserted 29 nt upstream of the TATA sequence (117 nt
from the ATG start site in the E1A gene). This insertion did not
negatively affect E1A transcription or viral packaging: RT-PCR re-
sults indicated that E1A and E1B mRNAs were as efﬁciently ex-
pressed as those in Ad11pwt and RCAd11pE3GFP viruses. Ad-
ditionally, a CPE was evident at 24 h p.i. for all viruses and con-
structs (Fig. 4C–E). These results indicate that the transcription
control region and packaging elements upstream of the insertion
site provide efﬁcient cis-acting induction of Ad transcription. Fur-
thermore, the cis-acting E1A gene product functioned similarly to
its wild-type counterpart in activating the transcription of the
delayed early viral genes, namely, the E1B, E2, E3, and E4 tran-
scriptional units (Gaynor and Berk, 1983; Nevins, 1981). Therefore,
cis-activation of the packaging domain and the E1A gene plays acritical role in maintaining the GFP cassette at 451 nt. This inser-
tion did not disrupt either the cis-acting transcription of the up-
stream packaging signal or downstream E1A gene expression. We
also veriﬁed the size of the gene cassette inserted in this region.
The RCAd11pE1GFP vector could efﬁciently encapsidate a genome
104.8% the size of the Ad11p genome. The full extent to which the
vectors could accept an insertion of additional DNA is yet to be
determined.
GFP expression mediated by RCAd11pE1GFP was higher than or
equal to GFP expression mediated by RCAd11pE3GFP. These results
match the native biological properties of Ad (Sharp and Flint,
1976). The oncolytic effects of the RCAd11pe1GFP vector on colon
and prostate cancer cells have been demonstrated in vivo and in
vitro in animal models (Smith et al., 2009). These viruses mani-
fested strong cytolytic and oncolytic effects in vitro and in vivo
(Silver and Mei, 2011). In addition, the RCAd11pe1GFP vector has
been used for the high-throughput screening of anti-Ad pharma-
ceuticals, resulting in the development of a promising anti-Ad
drug (Andersson et al., 2010). Conveniently, RCAd11p vectors do
not require a special packaging cell line for transfection and pro-
pagation. More importantly, the RCAd11p viruses replicated
quickly and effectively within 4–5 days following transfection with
either linear or circular Ad11p DNA in mammalian cells. High DNA
copy numbers and high yields of virus particles (Z5.41013) that
were on the same levels as those obtained with wild-type virus
were achieved. The full extent of Ad11p E1 insertion capacity re-
mains to be elucidated. Overall, these vectors may prove useful
tools for the investigation of fundamental cellular processes.
The expression of the E3 ORFs was delayed in comparison to
that of the E1 ORFs. The E3 region encodes proteins involved in
Fig. 4. Heat stabilities of Ad11pwt, RCAd11pE1GFP, RCAd11pE3GFP, and Ad11pe1DelGFP as measured using Trophos equipment. (A) The four Ad11p viruses at a con-
centration of 1 mg/ml in 50 ml PBS were exposed to 47 °C for 15 min, 30 min, 1 h, and 2 h. The transducing units of virus in A549 cells were then determined to assess the
presence of any remaining infectious virions following the heat treatment. Survival percentage was counted based on data obtained from a Trophos plate reader. There were
twice as many ﬂuorescence-positive cells after the heat treatment compared to an untreated cell population. (B) Ad11pwt, RCAd11pE1 and RCAd11pE3 viruses were
stringently treated at 47 °C for 5 h. (C) Ad11pwt, RCAd11pE1 and RCAd11pE3 viruses were heat stressed at 50 °C for 30 min. All experiments were performed three times,
with duplicate samples in each experiment. Error bars represent the mean 7SD. n.s.¼not signiﬁcant, *Po0.05, **Po0.01, ***Po0.001.
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fected cells (Wold et al., 1999). Several proteins play a critical role
in the early and late phases of the inﬂammatory response, which
eliminates infected cells. Although this study and others have
shown that the manipulation of the E3 region or a transgene in-
sertion can result in high levels of tumor-speciﬁc transgene ex-
pression, they also result in the deletion of certain genes from the
E3 region. Recent studies have shown that deletions of either all or
part of the E3 region may have a deleterious effect on the in vivo
oncolytic activity of the vector. From the gene product point of
view, short deletions are preferred over large deletions, as re-
ported by Mittal et al. (1995).
The Ad vector ﬁeld has typically focused on the function of
expression cassettes and has largely ignored virus stability, in-
fectivity and replication. The heat stability of wild-type Ad5 and
the defective Ad5 vector was previously evaluated at 45 °C or 47 °C
for periods ranging from 15 min to 2 h. Ad5 vectors with E1 de-
letions are commonly heat labile, which can affect their infectivity.
For example, Ad5-IX-RFP vectors become completely inactive after
being incubated at 45 °C for 20 min (Hoffmann et al., 2007). To
overcome this limitation, we developed novel strategies for the
insertion of expression cassettes into the Ad11p viral genome,
resulting in viruses that were more stable than wild-type.The RCAd11pE3 vector created in this study could tolerate heat
stress. Our unpublished data show that after keeping the four
viruses described here at 80° for 5 years in 10% glycerol PBS
solution, the RCAd11pE1 and RCAd11pE3 viruses showed much
higher titers than Ad11pwt, whereas the Ad11pE1Del vector
completely lost its infectivity. These unpublished data support the
present heat stability results from the replication-competent
Ad11p vectors. Taken together, the high yield and stability of the
Ad11p viruses studied here are of practical importance, as the
quantities and qualities of the RCAd11pe1 and RCAd11pE3 vectors
were sufﬁcient for experimental investigation.
The use of an expression cassette with a strong promoter was
found to be superior to placing an inserted gene under the control
of the E3 promoter. In the RCAd11pE3GFP vector presented in this
report, we maintained the E3A18.5 K ORF of Ad11p, corresponding
to E3A19K in Ad5. The 20.3 and 20.6 kD E3 proteins of Ad11p are
typically found in species B adenovirus genomes and are not
present in the Ad5 genome. Additionally, their functions are un-
known. We removed these two ORFs to create more space for
insertions. After the two E3 ORFs were replaced with a GFP ex-
pression cassette, RCAd11pE3 did not show any signiﬁcant al-
terations in terms of infectivity or replication compared with wild
type Ad11p. Thus, the virulence of RCAd11pE3GFP was maintained.
Fig. 5. Ultra-structures of adenovirus 11p particles under electron microscopy. (A) Ad11pwt before heat treatment (upper) and after heat treatment at 47 °C for 5 h (lower).
(B) RCAd11pE1GFP before heat treatment (upper) and after heat treatment at 47 °C for 5 h (lower). (C) RCAd11pE3GFP before heat treatment (upper) and after heat treatment
at 47 °C for 5 h (lower). (D) Ad11pE1DelGFP before heat treatment (upper) and after heat treatment at 47 °C for 5 h (lower).
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48.88%, 48.79%, 49.11% and 49.12% of the genomes of Ad11pwt,
E1GFP, E3GFP and E1DelGFP, respectively, were composed of GC
residues. Based on these values, it is unlikely that GC content af-
fected the thermal stability of these viruses, as the E1DelGFP
vector had the highest GC content but was the most labile virus in
this study. EM revealed that, following heat treatment, the E3GFP
sample had more full virus particles than empty particles, whereas
the E1GFP sample had nearly equivalent amounts of full and
empty virus particles. The Ad11pwt sample had a relatively higher
number of empty particles than full particles, and the E1DelGFP
sample contained mostly dissociated empty virus particles in
which the virus vertex proteins dissociated and the hexon proteins
were released from the capsids.The protein constituents of the E1GFP and E3GFP capsids were
identical to those of the Ad11pwt capsid with or without heat
treatment according to SDS-PAGE analysis. The Ad virion capsid is
composed of three major proteins: the penton base, ﬁber, and
hexon. Within the virion, pV is believed to form a shell around the
pVII-DNA complex (Brown et al., 1975) and tethers pVII-wrapped
DNA to the inner capsid (Chatterjee et al., 1985) through its direct
association with pVI (Matthews and Russell, 1998), which is di-
rectly connected to each peripentonal hexon (Stewart et al., 1993).
Thus, the only positions of contact between the viral DNA and the
capsid are at the vertices, which are bridged through pV. With
increased genome sizes, the E1GFP and E3GFP vectors showed
signiﬁcant stabilization of the capsid upon heating. Unfortunately,
we have not yet identiﬁed which protein or proteins at the vertices
Fig. 6. Virus titers (IP/VP) after heat stress. Ad11pwt, RCAd11pE1GFP, and RCAd11pE3GFP underwent heat treatment at 47 °C for 5 h, and untreated control viruses were used
for virus endpoint titration. Freshly cultivated A549 cells were seeded into 96-well plates and infected with 10-fold diluted viruses from 1 mg/well to 1011 dilution
(0.0001 pg/well or 0.36 vp/well). Every dilution was repeated in four wells. The results were calculated as the tissue culture infectious doses (TCID50). Visible cytopathic
effect (CPE) per well was counted as positive and evaluated until 14 days p.i. IP: infectious particle. VP: Total virus particles.
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gradation of these capsids based on SDS-PAGE (complementary
data).
From the virological point of view, the generation of physically
and biologically stable vectors is very important for clinical
translation. The disadvantage in gaining this stability is the
amount of time that is required to deﬁne insertion sites and the
effects associated with different substituted viral proteins. The
heat stability of Ad5 was previously investigated by Bett et al.
(1994). In the more than 20 years that have elapsed since this
report, several reports have investigated the heat stability of Ad
vectors harboring E1 deletions or decreased genomic sizes. How-
ever, there are few reports concerning how to approach studying
heat stability. A recent study using atomic force microscopy (AFM)
force measurements of Ad reported the internal capsid pressure of
Ad to be approximately 30 atm (Condezo et al., 2015; Ortega-Es-
teban et al., 2015). Internal capsid pressure can help release viral
DNA from the capsid and can also strengthen the capsid against
external deformation forces, as shown by AFM experiments in-
vestigating herpes virus and phage lambda (Bauer and Evilevitch,
2015; Bauer et al., 2015). The nature of the internal pressure cre-
ated by hydrated DNA is mainly entropic (Greber, 2016). Further
physical and structural studies might elucidate the novel and ex-
citing features of our RCAd11pE1GFP and RCAd11pE3GFP vectors
and show that they are important for infection.
In summary, we have deﬁned two important sites upstream of
the E1A and E3A regions of the Ad11p genome where the insertion
of a marker gene disrupts neither viral transcription nor replica-
tion. We also reported that, in addition to genome size, the choice
of an insertion/deletion site in the viral genome plays an im-
portant role in the heat stability of the virion. The novel RCAd11p
vectors developed here have the potential to advance oncolytic
virotherapy, as they offer solutions to many of the current lim-
itations associated with the use of Ad5. Our results demonstrated
that Ad11p can be produced at a high yield and with high stability.
These ﬁndings are especially important with regards to the pre-
sent interest in using viruses as cancer therapy vectors or ex-
pression vectors for vaccines. In particular, they demonstrate that
we have overcome the disadvantages associated with the use of
conventional Ad5 vectors, which harbor E1 gene deletions fol-
lowed by insertions of other therapeutic genes, resulting in con-
siderably reduced transactivation, transcription, and cell lysis.4. Materials and methods
4.1. Cell lines and cell culture
The A549 cell line was derived from a human oat-cell lung
carcinoma and was used in the experiments investigating viral
DNA transfections, virus preparations, and virus infections. A549
cells were obtained from Dr. Nelson-Rees W and were used for
clinical viral diagnosis at Umeå University and hospital (Lieber
et al., 1976). Additionally, low passage 293 cells (30–35 passages),
which were derived from human embryo kidney cells, were pur-
chased from Microbix Biosystems Inc., (Toronto, Ontario, Canada)
for use in the viral DNA transfection and viral infection experi-
ments. The human cell lines were supplemented with 10% fetal
calf serum (FCS) for 293 cells, and only 5% FCS for A549 was added.
Additionally, the media for all of the cell lines were supplemented
with 20 mM Hepes (pH 7.4), 0.75% NaCO3 (w/v), 100 U/ml peni-
cillin, and 100 μg/ml streptomycin.
4.2. Construction of replication-competent Ad11pE1GFP and Ad11-
pE3GFP vectors
Human adenovirus 11 prototype (Ad11p), strain Slobitski, was
chosen to construct a replication-competent species B Ad vector.
The following strategy was used to clone the complete Ad11
genome. First, a pUC19 plasmid carrying an ampicillin selection
cassette and a bacterial replicon was ﬂanked with an 899-bp
fragment of the 5′ terminal sequence of Ad11p and a 1100-bp
fragment of the 3′ terminal sequence. To accomplish this, the
plasmid was cut with Swa I to release its two termini. Second,
transformed BJ5183 bacterial cells expressing the bacterial DNA
polymerase were used to facilitate homologous recombination
between the linearized shuttle vector and the Ad11p genomic
DNA, resulting in the creation of pAd11p, as reported by Chartier
et al. (1996).
In BJ5183 bacterial cells, a shuttle vector carrying a 1729-bp
PCR fragment containing the cytomegalovirus (CMV) promoter,
the green ﬂuorescent protein (GFP) gene, and a SV40 poly-A se-
quence was used to insert this GFP cassette into the Ad11p genome
at nucleotide (nt) position 451. The cassette was inserted between
the packaging enhancer and the E1 promoter via homologous re-
combination (Fig. 1A and B). The resulting plasmid was designated
pAd11pe1GFP, and expression of this vector in cells resulted in the
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the E3 20.3 K and 20.6 K ORFs were deleted, and three cleavage
sites for Pme, Swa I, and Kpn I were introduced, in addition to a
Cre-lox site, within an E3 shuttle plasmid. The GFP reporter gene
was inserted into the Swa I site in the same orientation as the E3
promoter (Fig. 1D). The Cre-lox site could be useful in the future
for any tropism-related modiﬁcations of the ﬁber gene or the E4
region. Subsequently, the E3 shuttle plasmid DNA was inserted
into the Ad11p genome through homologous recombination in
BJ5183 bacterial cells to generate the RCAd11pe3GFP vector.
Both of our vector constructs (pAd11pE1GFP and pAd11-
pE3GFP) released Ad11p genomes carrying a GFP cassette in the
upstream E1 region or E3 region; this cassette was inserted via Not
I digestion. Linearized Ad11p DNAwith and without a GFP cassette
was transfected into HEK293 and A549 cells using Lipofectamine
2000 (Invitrogen). After 4–5 days of incubation, RCAd11pe1GFP
and RCAd11pe3GFP viruses were detected, and the infected cells
were harvested and maintained at 80 °C as viral stocks (Fig. 1A–
D.
4.3. Adenovirus 11p virus, replicating defective Ad11p virus, and
packaging cell lines
Human adenovirus 11 prototype (Ad11p), strain Slobitski, was
chosen to construct a replication-competent species B Ad vector.
The replication-defective Ad11p vector was created in the same
manner as the other conventional Ad vector constructs. The de-
fective Ad11p vector (Ad11pE1delGFP) was generated by deleting
the E1 region ORFs from the 5′-terminal nt positions 507–3405 bp
(2899 bp). A CMV-GFP-SV40 expression cassette was introduced
downstream of the packaging region at nt position 451 in a reverse
orientation. The Ad11pE1delGFP genome was released from
pAd11pe1delGFP via Not I digestion.
To construct complementary cell lines for packaging the
Ad11pe1Del vector, the following procedure was employed. A QBI-
pgk plasmid (Promega) was used to clone the Ad11pe1 region. The
5′-terminal nts 507-3405, corresponding to the E1 region; 1915–
3399, corresponding to the 55K region; or 3483–3902, corre-
sponding to a region encoding protein IX in the Ad11p genome,
were cloned into the QBI pgk vector, replacing the GFP gene. The
plasmids expressing the E1, 55K, or pIX genes were individually
cotransfected into HEK293 cells with Lipofectamine 2000. Three
cell lines were established using Geneticin as a selection agent.
4.4. RT-PCR to detect transcription of E1 gene mRNA
To validate that the insertion of GFP into the E1 region did not
prevent E1 gene transcription, three pairs of primers were syn-
thesized and used in an RT-PCR assay. A549 cells were infected
with RCAd11pE1 and RCAd11pE3 viruses, and at 7, 24, and 48 h. p.
i., the infected cells were harvested, washed once and resuspended
in PBS. Total RNA was isolated with TRIzol (Invitrogen) according
to the manufacturer's instructions. Next, 1 μg of total RNA was
treated with DNase I (Invitrogen), and cDNAwas synthesized using
reverse transcriptase (Promega, Madison, WI) in a volume of 20 ml.
For RT-PCR analysis, 2 ml of cDNA was used. Three primer pairs
were used to detect sequences encoding the E1A and E1B proteins,
as follows: E1A (forward), 5′-ATGAGAGATTTGCGATTTC-3′; E1A
(reverse), 5′-GTGCTTGAATCTCAGGAG-3′; E1B 55K (forward), 5′-
ATGGATCCCGCAGACTC-3′; E1B 55K (reverse), 5′-CTCACCTTAGT-
CAGTTTCTT-3′; E1B pIX (forward), 5′-ATGAGTGGAAACGCTTCT-3′;
E1B pIX (reverse): 5′-TTATTTAGACTTTGCCGTGC-3′. For all three
sets of primers, 50 ml of the PCR reaction mixture was subjected to
35 cycles of 1 min at 94 °C, 30 s at 52 °C, and 30 s at 72 min. The
PCR products were analyzed on a 1% agarose gel.4.5. qPCR to detect expression of the E1A and hexon genes
A total of 1.5106 cells were individually infected with 0.1 pg/
cell RCAd11pE1, RCAd11pE3 and Ad11pwt. After incubating the
viruses with the cells at 37 °C for one hour, the cells were washed
twice with DMEM, and culture medium containing 2% FCS DMEM
was added. The cells were then incubated in the medium for 2, 8,
24, 48 and 72 h. Total cellular RNA was isolated using TRIzol LS
reagent (Life Technologies). The samples were treated with DNase
I and converted into cDNA using Moloney Murine Leukemia Re-
verse Transcriptase (m-MLV RT) reagent (Invitrogen). qPCR was
performed using SYBR Green MasterMix (Life Technologies) in a
Step One Plus real-time PCR system (Applied Biosystems). The
following primers were used to detect the expression of the Ad11p
E1A and hexon genes: E1A-F primer 5′ GTCCTGTGTCTGATGCT-
GATGAAT-3′; E1A-R primer 5′-ACAGGAATGGGCTTGCGCAC-3′.
Brieﬂy, quantitative real-time PCR was carried out using the fol-
lowing degenerate primer pair: Kadgen1 (forward), 5′-CWT ACA
TGC ACA TCK CSG G-3′; Kadgen2 (reverse), 5′-CRC GGG CRA AYT
GCA CCA G-3′ (DNA Technology A/S, Aarhus, Denmark). This pri-
mer pair is speciﬁc for the conserved region of the Ad11p hexon
gene and can detect all human Ads (Andersson et al., 2010).
4.6. Preparation of virus particles
To obtain a high viral yield, different inoculation doses of virus
were evaluated in A549 cells. As a result, we determined that a
virus dose of approximately 50–150 ml per 175 cm2 bottle could be
harvested at 3.5 to 4 days post infection. At this dose and time
point, the majority of progeny viruses was localized intracellularly
and had not yet been released into the cell supernatant.
To create a large preparation of Ad, a total of 1108 A549 cells
per 175 cm2 bottle were infected with RCAd11pE1, RCAd11pE3 or
Ad11pwt viruses; a total of 20 bottles of cells were used per
construct. After the infected cells achieved a full cytopathic effect
(CPE) approximately 3–4 days post infection (p.i.), they were har-
vested by centrifugation at 800 rpm for 5 min. Next, the cells were
sonicated twice at 30% power and 4 °C for 10 s. The cell lysate was
extracted once with chloroform, and the viral supernatant was
obtained after centrifuging the lysate at 3000 rpm for 1 min. Next,
gradient ultracentrifugation was performed according to our pre-
vious publication (Havenga et al., 2002; Mei et al., 1998). The viral
yields from the RCAd11pE1GFP and RCAd11pE3GFP cultures were
compared to that of the Ad11pwt culture. The infectivity of the
viral particles was determined by measuring the 50% tissue culture
infection dose (TCID50) in A549 cells as previously described (Mei
et al., 1998). The morphologies of the puriﬁed virions were also
examined using electron microscopy.
4.7. Heat stability assay
To test whether the RCAd11pE1GFP and RCAd11pE3GFP inser-
tions destabilize the Ad capsid structure, we exposed the viruses
to 47 °C for 15 min, 30 min, 1 h, and 2 h and then determined the
infectivity of each sample to assess the presence of any remaining
infectious virions that survived the heat treatment. The viruses
were further stringently treated at 47 °C for 5 h and at 50 °C or
55 °C for 30 min, after which the biological titers of the untreated
and treated viruses were determined in A549 cells.
The infectivity of replicating Ad11p viruses was measured as
follows: 1.5104 A549 cells were seeded per well in a 96-well
plate and then incubated at 37 °C overnight. The next day, the cells
were infected with 10-fold dilutions of virus, ranging from 1 mg/
well to 1011 mg/well. The ﬁnal concentration was 0.36 vp/well
(1104 pg/well). At 48 h p.i., the cells that were infected with
GFP-expressing viruses were directly measured for GFP expression
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Ad11pwt were centrifuged at 300g for 5 min, after which their
media was aspirated. They were then washed once with 200 ml PBS
and ﬁxed with 100 ml 3% PFA PBS for 30 min at RT. The cells were
labeled using a rabbit anti-Ad11p antibody (KS590, virus lab UmU),
which was diluted 1:1000 in PBS. For the labeling, the cells were
incubated with the antibody while shaking at 4 °C for 1 h and then
washed three times with PBS. The cells were then visualized using
donkey anti-rabbit IgG (HþL) conjugated with Alexa Flour 488
(Invitrogen molecular probe, Cat no R37118) at a 1:500 dilution in
addition to 1:5000 DAPI for 30 min at 4 °C. The cells were then
washed with PBS three times, and their ﬂuorescence was mea-
sured using a Trophos plate reader.
4.8. Electron microscopy
Adenoviruses were puriﬁed before and after heat treatment at
47 °C for 5 h and then stained with 2% potassium phosphotungstic
acid and examined by direct electron microscopy (EM). A random
selection of at least ﬁve areas per virus or vector was photo-
graphed. The number of intact virus particles versus total virus
particles was calculated.
4.9. Statistical analysis
Statistical analyses (t tests) were performed with GraphPad
Prism software version 7 (GraphPad Software, San Diego, CA).Conﬂicts of interest
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